z-logo
open-access-imgOpen Access
A Hybrid Glioma Tumor Cell Lysate Immunotherapy Vaccine Demonstrates Good Clinical Efficacy in the Rat Model [Corrigendum]
Author(s) -
Xinlong Li,
Shan Zeng,
He Haiping,
Xu Zeng,
Lilei Peng,
Ligang Chen
Publication year - 2022
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s372818
Subject(s) - immunotherapy , glioma , medicine , lysis , clinical efficacy , computational biology , cancer research , immunology , immune system , biology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom